{"id":"NCT05099640","sponsor":"PTC Therapeutics","briefTitle":"A Study of PTC923 in Participants With Phenylketonuria","officialTitle":"A Phase 3 Study of PTC923 in Subjects With Phenylketonuria","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-09-30","primaryCompletion":"2023-04-03","completion":"2023-05-03","firstPosted":"2021-10-29","resultsPosted":"2024-01-10","lastUpdate":"2024-01-10"},"enrollment":157,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Phenylketonuria"],"interventions":[{"type":"DRUG","name":"PTC923","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Part 1: PTC923","type":"EXPERIMENTAL"},{"label":"Part 2: PTC923","type":"EXPERIMENTAL"},{"label":"Part 2: Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this trial is to evaluate the efficacy of PTC923 in reducing blood phenylalanine (Phe) levels in participants with phenylketonuria as measured by mean change in blood Phe levels from baseline to Weeks 5 and 6 (that is, the average of each respective treatment dose 2-week period of double-blind treatment).","primaryOutcome":{"measure":"Part 2 Double-blind Phase: Mean Change From Baseline in Blood Phenylketonuria (Phe) Level to Weeks 5 and 6 (Averaged Over a 2-week Period) in Participants With Phe Reduction From Baseline ≥30% During Part 1","timeFrame":"Baseline, Weeks 5 and 6 (average of the 2-week period)","effectByArm":[{"arm":"Part 2: Sepiapterin","deltaMin":-415.75,"sd":24.066},{"arm":"Part 2: Placebo","deltaMin":-19.88,"sd":24.223}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":43,"countries":["United States","Australia","Brazil","Canada","Denmark","France","Georgia","Germany","Italy","Mexico","Netherlands","Portugal","Spain","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["39368841"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":157},"commonTop":["Diarrhoea","Upper respiratory tract infection","Gastroenteritis","Headache","Nasopharyngitis"]}}